BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6
19 results:

  • 1. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.
    Shaim H; Shanley M; Basar R; Daher M; Gumin J; Zamler DB; Uprety N; Wang F; Huang Y; Gabrusiewicz K; Miao Q; Dou J; Alsuliman A; Kerbauy LN; Acharya S; Mohanty V; Mendt M; Li S; Lu J; Wei J; Fowlkes NW; Gokdemir E; Ensley EL; Kaplan M; Kassab C; Li L; Ozcan G; Banerjee PP; Shen Y; Gilbert AL; Jones CM; Bdiwi M; Nunez-Cortes AK; Liu E; Yu J; Imahashi N; Muniz-Feliciano L; Li Y; Hu J; Draetta G; Marin D; Yu D; Mielke S; Eyrich M; Champlin RE; Chen K; Lang FF; Shpall EJ; Heimberger AB; Rezvani K
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34138753
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/tgfbr2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract.
    Roos E; Soer EC; Klompmaker S; Meijer LL; Besselink MG; Giovannetti E; Heger M; Kazemier G; Klümpen HJ; Takkenberg RB; Wilmink H; Würdinger T; Dijk F; van Gulik TM; Verheij J; van de Vijver MJ
    Crit Rev Oncol Hematol; 2019 Aug; 140():8-16. PubMed ID: 31158800
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.
    Wang Q; Cai J; Fang C; Yang C; Zhou J; Tan Y; Wang Y; Li Y; Meng X; Zhao K; Yi K; Zhang S; Zhang J; Jiang C; Zhang J; Kang C
    Theranostics; 2018; 8(17):4733-4749. PubMed ID: 30279734
    [No Abstract]    [Full Text] [Related]  

  • 5. Lnc-SNHG1 Activates the tgfbr2/SMAD3 and RAB11A/Wnt/β-Catenin Pathway by Sponging MiR-302/372/373/520 in Invasive Pituitary Tumors.
    Wang H; Wang G; Gao Y; Zhao C; Li X; Zhang F; Jiang C; Wu B
    Cell Physiol Biochem; 2018; 48(3):1291-1303. PubMed ID: 30048990
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Synthesis of pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3-triazoles and their evaluation as potential anticancer agents.
    Allam M; Bhavani AKD; Mudiraj A; Ranjan N; Thippana M; Babu PP
    Eur J Med Chem; 2018 Aug; 156():43-52. PubMed ID: 30006173
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Viscumins functionally modulate cell motility-associated gene expression.
    Schötterl S; Hübner M; Armento A; Veninga V; Wirsik NM; Bernatz S; Lentzen H; Mittelbronn M; Naumann U
    Int J Oncol; 2017 Feb; 50(2):684-696. PubMed ID: 28101577
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.
    Du C; Pan P; Jiang Y; Zhang Q; Bao J; Liu C
    World J Surg Oncol; 2016 Oct; 14(1):258. PubMed ID: 27716259
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
    Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
    Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
    Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
    Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway.
    He X; Liu Z; Peng Y; Yu C
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1041-8. PubMed ID: 26682928
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (tgfbr2) as a Novel Regulator of Glioblastoma Stem Cell Properties.
    Narushima Y; Kozuka-Hata H; Koyama-Nasu R; Tsumoto K; Inoue J; Akiyama T; Oyama M
    Mol Cell Proteomics; 2016 Mar; 15(3):1017-31. PubMed ID: 26670566
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.
    Kosaka A; Ohkuri T; Ikeura M; Kohanbash G; Okada H
    Biochem Biophys Res Commun; 2015 Mar; 458(3):549-554. PubMed ID: 25677619
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutational profiling of kinases in glioblastoma.
    Bleeker FE; Lamba S; Zanon C; Molenaar RJ; Hulsebos TJ; Troost D; van Tilborg AA; Vandertop WP; Leenstra S; van Noorden CJ; Bardelli A
    BMC Cancer; 2014 Sep; 14():718. PubMed ID: 25256166
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Analysis of microsatellite instability in medulloblastoma.
    Viana-Pereira M; Almeida I; Sousa S; Mahler-Araújo B; Seruca R; Pimentel J; Reis RM
    Neuro Oncol; 2009 Oct; 11(5):458-67. PubMed ID: 19179424
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. tgfbr2 gene expression and genetic association with schizophrenia.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Hashimoto R; Takeda M; Kunugi H; Itakura M; Ohmori T
    J Psychiatr Res; 2008 May; 42(6):425-32. PubMed ID: 17560608
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.
    Will O; Carvajal-Carmona LG; Gorman P; Howarth KM; Jones AM; Polanco-Echeverry GM; Chinaleong JA; Günther T; Silver A; Clark SK; Tomlinson I
    Gastroenterology; 2007 Feb; 132(2):527-30. PubMed ID: 17258725
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Distinct methylation profiles of glioma subtypes.
    Uhlmann K; Rohde K; Zeller C; Szymas J; Vogel S; Marczinek K; Thiel G; Nürnberg P; Laird PW
    Int J Cancer; 2003 Aug; 106(1):52-9. PubMed ID: 12794756
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
    De Rosa M; Fasano C; Panariello L; Scarano MI; Belli G; Iannelli A; Ciciliano F; Izzo P
    Oncogene; 2000 Mar; 19(13):1719-23. PubMed ID: 10763829
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.